AMAZON

As a fund, our unique model enables us to act quickly and effectively, with a proven ability to leverage efficiencies of the private sector and foster strong partnerships. We are able to mobilize resources from a diverse range of investors and direct them to partners who can deliver them where they will have the most impact. These strategic investments will help end the most prevalent NTDs by 2030... The END Fund focuses on delivering neglected tropical disease (NTD) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with government, NGO, pharmaceutical, and academic partners. We aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending NTDs... The END Fund is a private philanthropic initiative dedicated to ending neglected tropical diseases. The END Fund began working in 2012. In 2017, we..

Registration numbers: 1122574 (W), 6350698 (W), EIN 27-3941186 (W)

Primary location: New York United States